Caricamento...
Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global public health crisis. Effective COVID-19 vaccines developed by Pfizer-BioNTech, Moderna, and Astra Zeneca have made significant impacts in controlling the COVID-19 burden, especially in reducing the transmission of SARS...
Autori principali: | , , , , , |
---|---|
Natura: | Online Articolo testo |
Lingua: | English |
Pubblicazione: |
MDPI
2022
|
Soggetti: | |
Accesso online: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029629/ https://www.ncbi.nlm.nih.gov/pubmed/35457159 http://dx.doi.org/10.3390/ijms23084341 |